Pricing Log in Create free account
Saturday 17 October 2026 Export TECH’s income statement to Excel — free account

Bio-Techne Corp

TECH Healthcare Biotechnology

Bio-Techne Corp’s revenue for fiscal 2026 (year ended June 2026) was $1.2 billion, roughly unchanged from fiscal 2025. In the quarter to June 2026, revenue grew 1.33%, EPS grew 418.2%, free cash flow fell 6.83% and total debt fell 42.2%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for three consecutive years.

72.54 0.02 +0.03%
Market cap
$11.4B
P/E
62.0×
Fwd P/E
37.6×
Dividend yield
0.44%
F-score
9/9
Altman Z
15.50
Beneish M
−2.52
Dividend safety
78/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Bio-Techne Corp (TECH) EPS (diluted)

Alert me on EPS (diluted)

Bio-Techne Corp's EPS (diluted) for fiscal 2026 was $1.16, up 152.2% from $0.46 in fiscal 2025. Over the past ten years it has ranged from $0.46 (fiscal 2025) to $1.76 (fiscal 2023); the current reading is higher than 75% of that period. Bio-Techne Corp ranks 54th of 587 Biotechnology companies by EPS (diluted).

EPS (diluted), annual

Embed this chart

Annual newest first

Period EPS (diluted) Change
FY2026 $1.16 152.17%
FY2025 $0.46 (56.19%)
FY2024 $1.05 (40.34%)
FY2023 $1.76 6.18%
FY2022 $1.66 91.07%
FY2021 $0.87 (40.38%)
FY2020 $1.46 135.63%
FY2019 $0.62 (24.92%)
FY2018 $0.82 59.71%
FY2017 $0.52 (26.43%)

Quarterly newest first

Period EPS (diluted) Change
Jun 2026 $0.35 9.37%
Mar 2026 $0.32 33.33%
Dec 2025 $0.24 0.00%
Sep 2025 $0.24 —
42 more quarters

Against its own ten years

Low $0.46 High $1.76
Ten-year median $0.85
Current reading's percentile 75

EPS (diluted) against peers

Company EPS (diluted)
KRYS Krystal Biotech, Inc. compare $7.98
TECH Bio-Techne Corp $1.15
CORT Corcept Therapeutics Incorporated compare $0.42
BMRN BioMarin Pharmaceutical Inc. compare $0.37
IBRX ImmunityBio, Inc. compare −$0.97
SMMT Summit Therapeutics PLC compare −$1.12
BBIO BridgeBio Pharma, Inc. compare −$3.57
PCVX Vaxcyte, Inc. compare −$7.63
MDGL Madrigal Pharmaceuticals, Inc. compare −$12.89

What EPS (diluted) is

Diluted EPS tells an investor how much profit a company earned for each share, counting the extra shares that options and convertible securities could create.

Reported line item

The full definition of EPS (diluted) →

More on TECH